Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » ClearPoint Neuro to commercialize FDA-cleared neuro laser

ClearPoint Neuro to commercialize FDA-cleared neuro laser

By

Marketing image of the ClearPoint Prism neuro laser therapy system created by Clinical Laserthermia Systems and commercialized by ClearPoint Neuro
The ClearPoint Prism neuro laser therapy system [Image courtesy of ClearPoint Neuro]
ClearPoint Neuro (Nasdaq: CLPT) announced today that the FDA has cleared its Swedish partner Clinical Laserthermia Systems’ neuro laser therapy system.

The plan is for ClearPoint Neuro to commercialize the system as the ClearPoint Prism. The company has exclusive global rights to commercialize the CLS magnetic resonance (MR) guided laser interstitial thermal therapy (MRgLITT) system. The system is for neuro applications.

The ClearPoint Neuro navigation system has FDA clearance and a CE mark. The company has it installed in over 60 active sites in the United States, Canada, and Europe. In addition, the company has partnerships with more than 45 pharmaceutical and biotech companies. Applications it’s pursuing include drug delivery to the brain. Also, ClearPoint Neuro is active in the hot brain-computer interface space. It is working with Blackrock Neurotech to automate BCI implantation.

“Over the past decade, the ClearPoint Neuro Navigation System has offered an efficient one-room solution to assist neurosurgeons in the United States and Europe to accurately place laser fibers and help treat brain tumors, radiation necrosis, and epileptic foci in thousands of patients,” ClearPoint Neuro CEO Joe Burnett said in a news release.

Burnett said the company looks forward to commercializing the laser therapy treatment in the coming years. “This is another example of the innovation that ClearPoint is delivering to the neurosurgery and spine community through our team and our expert partners.”

More about ClearPoint Prism

Laser interstitial thermal therapy could prove to be a minimally invasive and powerful treatment for various neurological diseases, according to Dr. John Rolston, director of the Mapping & Engineering Neural Dynamics Laboratory at Brigham & Women’s Hospital and Harvard Medical School.

“The new laser system offered by ClearPoint has several exciting technical innovations that are expected to make this therapy simpler and more accessible to surgeons and their patients,” Rolston said.

The ClearPoint Prism neuro laser therapy system is currently in a limited market release. It’s at select academic medical centers in the United States.

In case you missed it

RSS From Medical Design & Outsourcing

  • Synchron’s plan to beat Neuralink in the neuroprosthetic BCI race
    Competing brain-computer interface (BCI) developers Synchron and Neuralink both announced big news this month as they move their dueling neuroimplant technologies forward. The device developers each have FDA investigational device exemption (IDE) for their experimental BCIs. They’ve also got billionaires backing their R&D and regulatory efforts, with Neuralink owned by Elon Musk and Synchron funded… […]
  • How LimFlow’s foot-saving system prevents amputations in patients with no other options
    LimFlow’s breakthrough system for treating chronic limb-threatening ischemia (CLTI) is the first of its kind approved by the FDA for this severe form of peripheral artery disease (PAD). For CLTI patients who have lost blood flow below their knee and have no other suitable endovascular or surgical treatment options available, the LimFlow System for Transcatheter… […]
  • Device strategies to prevent healthcare-associated infections
    Device design, sterilization before use and proper cleaning of reusable equipment can prevent infections and save lives. By Ted Eveleth, AvantGuard Nosocomial infections, also commonly known as healthcare-associated infections (HAIs), are a multibillion-dollar problem and a leading cause of morbidity and mortality around the world. On any given day, about 1 in 31 hospital patients… […]
  • MGS breaks ground on innovation and tech center
    MGS has started construction of its new innovation center at its headquarters campus in Germantown, Wisconsin. The medtech contract manufacturer said the 120,000 ft² facility is scheduled to open by the end of 2024. The MGS expansion will have collaborative workspaces dedicated to ideation and product development, tooling development, automation, and part and process validation,… […]
  • Two-armed surgical robot prototype targets pediatric brain tumors
    Researchers say they’ve developed a surgical robot for removing brain tumors in children, and that it could also offer a less invasive, safer option for adult neurosurgery and other procedures. The trick is using hollow, nitinol robot arms to allow neurosurgeons to swap tools during a tumor resection procedure, said Pierre DuPont. He’s the chief… […]
  • S3 Connected Health joins DiMe’s International Regulatory Pathways project
    NEWS RELEASE: S3 Connected Health joins DiMe’s team of digital health experts in their new project ‘International Regulatory Pathways’ DUBLIN, September 19, 2023 – Building on the success of the Digital Health US Regulatory Pathways, DiMe has assembled a global team of digital health experts, including S3 Connected Health, to support digital health product developers… […]
  • Four steps medtech startups can’t put off
    Developing and commercializing a new medical device is a success worth toasting for medtech startups — but that success also makes it more likely that litigation is in their future. There are steps medtech startups can take to protect themselves down the road, said Greenberg Traurig shareholder Ginger Pigott, a litigator who defends major medical… […]
  • How Biosense Webster aims to expand access to AFib care
    Electrophysiology is “an incredibly vibrant space,” said Nikki Sidi, but access remains a challenge. Nikki Sidi, the U.S. president of Johnson & Johnson’s Biosense Webster, can look at her own company as one of those paving the way in electrophysiology (EP). Its recent milestones include multiple atrial fibrillation (AFib) mapping catheters, including ablation and mapping devices. … […]
  • Tessy Plastics announces CEO and president transitions
    Tessy Plastics today named Stafford Frearson as the medtech supplier’s new president with former President Roland Beck becoming CEO. Frearson joined the contract manufacturer in 1997 and was promoted to his most recent role, VP of engineering, in 2018. He’s now responsible for day-to-day business operations across the plastics company’s 13 locations in the U.S.… […]
  • Accumold details injection molding of thin wall cannulas
    NEWS RELEASE: Injection molding of thin wall cannulas — a lesson in expertise and persistence After 5 years of painstaking work, leading micro molding innovator Accumold has developed a way to micro injection mold thin wall cannulas in very high volumes. Previous to this innovative approach to production, cannulas were typically produced via an extrusion… […]
  • How exposed are Medtronic, Intuitive and other Medtech Big 100 device makers to China?
    As economic concerns shift from the U.S. to China, medical device manufacturers such as Medtronic and Intuitive are monitoring how procedure volumes and new policies affect their businesses. In a new note, William Blair analyst Brandon Vazquez details the exposure of those companies and four more on Medical Design & Outsourcing‘s Medtech Big 100 ranking… […]

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Copyright © 2023 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy